EMERYVILLE, Calif., Nov. 20, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28 at 4:40 p.m. ET.
SEOUL, South Korea, Sept. 19, 2023 /PRNewswire/ -- ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities.
ST Pharm Co., Ltd. (237690:KOSDAQ) announced on 3rd August that the Phase 1 clinical trial results of STP0404, the HIV treatment candidate, was...
ST Pharm announced on Monday it won the U.S. FDA’s current Good Manufacturing Practice (cGMP) certification for its oligonucleotide (oligo) plant in Korea, for the first time in Asia.
ST Pharm said it was having a pre-IND (investigational new drug) meeting with the U.S. FDA for a phase 2 trial of an HIV drug, after completing the phase 1 study in France.
ST Pharm Co. Ltd., an API CDMOnin the Republic of Korea, plans to build a second oligonucleotide nmanufacturing plant to expand production facilities and to accommodate nthe rapidly growing oligonucleotide Therapeutics market.
Two more local companies have newly joined the “K-mRNA vaccine consortium,” a local alliance of pharmaceutical companies dedicated to co-developing and co-producing homegrown messenger RNA vaccines.
The stock of India’s second largest pharma company by market capitalisation, Divi’s Laboratories was down a tad on Monday despite better than expected operating performance. The flattish stock performance was on account of expensive valuations and worries of whether margins are peaking out.
Anglo-Swedish drugmaker AstraZeneca revealed on Thursday it plans to seek full U.S. authorization for its Covid-19 vaccine in the second half of the year following strong global sales of the shot, further delaying its entry to the world’s largest pharmaceutical market after facing numerous setbacks and eschewing the faster emergency application.